Intercept Pharmaceuticals, Inc.

Rafferty Asset Management, LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

306,233

Value ($000)

5,678

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	5,678	0.0%	306,233	9/30/2023
2023 Q2	8/11/2023	4,560	0.0%	412,274	6/30/2023
2023 Q1	5/11/2023	3,498	0.0%	260,425	3/31/2023
2022 Q4	2/13/2023	3,289	0.0%	265,917	12/31/2022
2022 Q3	11/14/2022	3,147	0.0%	225,604	9/30/2022
2022 Q2	8/12/2022	2,116	0.0%	153,193	6/30/2022
2022 Q1	5/13/2022	3,707	0.0%	227,843	3/31/2022
2021 Q4	2/10/2022	4,233	0.0%	259,839	12/31/2021
2021 Q3	11/10/2021	2,192	0.0%	147,600	9/30/2021
2021 Q2	8/10/2021	2,416	0.0%	120,991	6/30/2021
2021 Q1	5/10/2021	3,660	0.0%	158,592	3/31/2021
2020 Q4	2/10/2021	750	0.0%	30,355	12/31/2020
2020 Q3	11/13/2020	1,973	0.0%	47,581	9/30/2020
2020 Q2	8/7/2020	609	0.0%	12,704	6/30/2020
2020 Q1	5/15/2020	243	0.0%	3,858	3/31/2020
2019 Q4	2/10/2020	4,073	0.1%	32,865	12/31/2019